PIPRACIL (piperacillin sodium) · Pfizer
PIPRACIL is FDA-approved to treat 7 conditions (same as PIPERACILLIN).
Details
- Status
- Discontinued
- First Approved
- 1981-12-29
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
PIPRACIL Approval History
What PIPRACIL Treats
7 indicationsPIPRACIL is approved for 7 conditions since its original approval in 1981. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Intra-abdominal Infections
- Nosocomial Pneumonia
- Skin and Skin Structure Infections
- Female Pelvic Infections
- Community-Acquired Pneumonia
- Appendicitis
- Peritonitis
Same approved indications as PIPERACILLIN (same active ingredient).
Pfizer's other novel FDA approvals
Other CDER-designated drugs from the same sponsor (2016–2025).
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PIPRACIL FDA Label Details
Indications & Usage
FDA Label (PDF)PIPRACIL is FDA-approved to treat 7 conditions — same approved indications as PIPERACILLIN.
Track PIPRACIL with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.